Agenus Inc. , a leader in immuno-oncology, today shared new data on botensilimab (BOT) and balstilimab (BAL) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) ...

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...

Masco Corporation (MAS), headquartered in Livonia, Michigan, is a global leader in designing, manufacturing, and distributing ...

First-ever corporation to top Corporate Knights Global 100 twice14th consecutive year in Global 100 index, 7th top 10 ranking  Follows strong 2024 performance in other key ESG ratings ...

The leading and longest established online Process Engineering publication serving the Process Manufacturing Industries ...

This Phase 1b/2, open-label, multicenter dose escalation and expansion combination study of ADG126 in combination with Merck’s (known as MSD outside of the US and Canada) anti-PD-1 therapy, KEYTRUDA ® ...

BAKU, Azerbaijan, January 13. A range of watercrafts owned by the Azerbaijan Caspian Shipping Company (ASCO) CJSC is now up ...

ASCO-GI plans to release further details for regular abstracts ... and enhanced visibility into the size and timing of capital expenditures related to our manufacturing facilities. 43 rd Annual J.P.

NDAQ:CRBU) Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 ...